Cargando…
Author Correction: Oral immunotherapy combined with omalizumab for high–risk cow’s milk allergy: a randomized controlled trial
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6102225/ https://www.ncbi.nlm.nih.gov/pubmed/30127456 http://dx.doi.org/10.1038/s41598-018-30919-3 |
| _version_ | 1783349113673220096 |
|---|---|
| author | Takahashi, Masaya Soejima, Kazuhiko Taniuchi, Shoichiro Hatano, Yasuko Yamanouchi, Sohsaku Ishikawa, Hideki Irahara, Makoto Sasaki, Youhei Kido, Hiroshi Kaneko, Kazunari |
| author_facet | Takahashi, Masaya Soejima, Kazuhiko Taniuchi, Shoichiro Hatano, Yasuko Yamanouchi, Sohsaku Ishikawa, Hideki Irahara, Makoto Sasaki, Youhei Kido, Hiroshi Kaneko, Kazunari |
| author_sort | Takahashi, Masaya |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6102225 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-61022252018-08-27 Author Correction: Oral immunotherapy combined with omalizumab for high–risk cow’s milk allergy: a randomized controlled trial Takahashi, Masaya Soejima, Kazuhiko Taniuchi, Shoichiro Hatano, Yasuko Yamanouchi, Sohsaku Ishikawa, Hideki Irahara, Makoto Sasaki, Youhei Kido, Hiroshi Kaneko, Kazunari Sci Rep Author Correction Nature Publishing Group UK 2018-08-21 /pmc/articles/PMC6102225/ /pubmed/30127456 http://dx.doi.org/10.1038/s41598-018-30919-3 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Author Correction Takahashi, Masaya Soejima, Kazuhiko Taniuchi, Shoichiro Hatano, Yasuko Yamanouchi, Sohsaku Ishikawa, Hideki Irahara, Makoto Sasaki, Youhei Kido, Hiroshi Kaneko, Kazunari Author Correction: Oral immunotherapy combined with omalizumab for high–risk cow’s milk allergy: a randomized controlled trial |
| title | Author Correction: Oral immunotherapy combined with omalizumab for high–risk cow’s milk allergy: a randomized controlled trial |
| title_full | Author Correction: Oral immunotherapy combined with omalizumab for high–risk cow’s milk allergy: a randomized controlled trial |
| title_fullStr | Author Correction: Oral immunotherapy combined with omalizumab for high–risk cow’s milk allergy: a randomized controlled trial |
| title_full_unstemmed | Author Correction: Oral immunotherapy combined with omalizumab for high–risk cow’s milk allergy: a randomized controlled trial |
| title_short | Author Correction: Oral immunotherapy combined with omalizumab for high–risk cow’s milk allergy: a randomized controlled trial |
| title_sort | author correction: oral immunotherapy combined with omalizumab for high–risk cow’s milk allergy: a randomized controlled trial |
| topic | Author Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6102225/ https://www.ncbi.nlm.nih.gov/pubmed/30127456 http://dx.doi.org/10.1038/s41598-018-30919-3 |
| work_keys_str_mv | AT takahashimasaya authorcorrectionoralimmunotherapycombinedwithomalizumabforhighriskcowsmilkallergyarandomizedcontrolledtrial AT soejimakazuhiko authorcorrectionoralimmunotherapycombinedwithomalizumabforhighriskcowsmilkallergyarandomizedcontrolledtrial AT taniuchishoichiro authorcorrectionoralimmunotherapycombinedwithomalizumabforhighriskcowsmilkallergyarandomizedcontrolledtrial AT hatanoyasuko authorcorrectionoralimmunotherapycombinedwithomalizumabforhighriskcowsmilkallergyarandomizedcontrolledtrial AT yamanouchisohsaku authorcorrectionoralimmunotherapycombinedwithomalizumabforhighriskcowsmilkallergyarandomizedcontrolledtrial AT ishikawahideki authorcorrectionoralimmunotherapycombinedwithomalizumabforhighriskcowsmilkallergyarandomizedcontrolledtrial AT iraharamakoto authorcorrectionoralimmunotherapycombinedwithomalizumabforhighriskcowsmilkallergyarandomizedcontrolledtrial AT sasakiyouhei authorcorrectionoralimmunotherapycombinedwithomalizumabforhighriskcowsmilkallergyarandomizedcontrolledtrial AT kidohiroshi authorcorrectionoralimmunotherapycombinedwithomalizumabforhighriskcowsmilkallergyarandomizedcontrolledtrial AT kanekokazunari authorcorrectionoralimmunotherapycombinedwithomalizumabforhighriskcowsmilkallergyarandomizedcontrolledtrial |